202 related articles for article (PubMed ID: 31500023)
1. Magnetic Janus particles as a multifunctional drug delivery system for paclitaxel in efficient cancer treatment.
Feng ZQ; Yan K; Li J; Xu X; Yuan T; Wang T; Zheng J
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():110001. PubMed ID: 31500023
[TBL] [Abstract][Full Text] [Related]
2. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
[TBL] [Abstract][Full Text] [Related]
3. Degradable porous drug-loaded polymer scaffolds for localized cancer drug delivery and breast cell/tissue growth.
Obayemi JD; Jusu SM; Salifu AA; Ghahremani S; Tadesse M; Uzonwanne VO; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110794. PubMed ID: 32409024
[TBL] [Abstract][Full Text] [Related]
4. Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential.
Fernandes E; Ferreira D; Peixoto A; Freitas R; Relvas-Santos M; Palmeira C; Martins G; Barros A; Santos LL; Sarmento B; Ferreira JA
Int J Pharm; 2019 Oct; 570():118646. PubMed ID: 31465836
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel and etoposide-loaded Poly (lactic-co-glycolic acid) microspheres fabricated by coaxial electrospraying for dual drug delivery.
Zhang M; Tang Y; Zhu Z; Zhao H; Yao J; Sun D
J Biomater Sci Polym Ed; 2018 Nov; 29(16):1949-1963. PubMed ID: 29920151
[TBL] [Abstract][Full Text] [Related]
6. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic.
Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N
Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859
[TBL] [Abstract][Full Text] [Related]
7. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation of a new quinoxaline derivative in PLGA alters the pattern of its anticancer potency and induces apoptosis.
Saad EA; Waly HM
Cancer Chemother Pharmacol; 2019 Apr; 83(4):649-658. PubMed ID: 30648201
[TBL] [Abstract][Full Text] [Related]
9. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
11. HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation.
Duan T; Xu Z; Sun F; Wang Y; Zhang J; Luo C; Wang M
Biomed Pharmacother; 2019 Sep; 117():109121. PubMed ID: 31252265
[TBL] [Abstract][Full Text] [Related]
12. PTX-loaded three-layer PLGA/CS/ALG nanoparticle based on layer-by-layer method for cancer therapy.
Wang F; Yuan J; Zhang Q; Yang S; Jiang S; Huang C
J Biomater Sci Polym Ed; 2018 Sep; 29(13):1566-1578. PubMed ID: 29749303
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of paclitaxel-loaded reactive oxygen species and glutathione redox-responsive poly(lactic-co-glycolic acid) nanoparticles for controlled release in tumor cells.
Wang S; Han F; Xie L; Liu Y; Yang Q; Zhao D; Zhao X
Nanomedicine (Lond); 2022 Sep; 17(22):1627-1648. PubMed ID: 36636982
[No Abstract] [Full Text] [Related]
14. Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma.
Ganipineni LP; Ucakar B; Joudiou N; Riva R; Jérôme C; Gallez B; Danhier F; Préat V
J Drug Target; 2019; 27(5-6):614-623. PubMed ID: 30633585
[TBL] [Abstract][Full Text] [Related]
15. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
Layek B; Sadhukha T; Panyam J; Prabha S
Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
[TBL] [Abstract][Full Text] [Related]
16. Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly(ethylene glycol)-co-poly(trimethylene carbonate) polymer nanoparticles.
Jiang X; Xin H; Gu J; Du F; Feng C; Xie Y; Fang X
J Pharm Sci; 2014 May; 103(5):1487-96. PubMed ID: 24619482
[TBL] [Abstract][Full Text] [Related]
17. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, purification, and anticancer effect of magnetic Fe
Wang K; Hu H; Zhang Q; Zhang Y; Shi C
J Microencapsul; 2019 Jun; 36(4):356-370. PubMed ID: 31190597
[TBL] [Abstract][Full Text] [Related]
19. PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: Effects of particle size on drug release kinetics and cell viability.
Obayemi JD; Danyuo Y; Dozie-Nwachukwu S; Odusanya OS; Anuku N; Malatesta K; Yu W; Uhrich KE; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():51-65. PubMed ID: 27207038
[TBL] [Abstract][Full Text] [Related]
20. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]